X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment

Hok Leong Chin1, Chia-Yi Lin1, Oscar Hou-In Chou2

  • 1Department of Clinical Medical Science, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Acta Neurologica Belgica
|November 23, 2022
PubMed

Insights

X-linked dystonia parkinsonism (XDP) is a rare genetic movement disorder affecting Filipino males. This review details its cause, symptoms, diagnosis, and treatments for better understanding and future research.

Area of Science:

  • Neuroscience
  • Genetics
  • Rare Diseases

Background:

  • X-linked dystonia parkinsonism (XDP) is a rare, X-linked recessive degenerative movement disorder.
  • It predominantly affects individuals of Filipino descent, primarily males.
  • The condition is linked to genetic alterations in the TAF1/DYT3 transcription system.

Purpose of the Study:

  • To provide a comprehensive review of X-linked dystonia parkinsonism (XDP).
  • To summarize current knowledge on XDP's genetic causes, clinical presentation, diagnosis, and management.
  • To offer a synoptic overview for future research directions.

Main Methods:

  • Literature review of existing studies on XDP.
  • Synthesis of information regarding genetic mutations, clinical manifestations, and diagnostic criteria.
  • Compilation of current treatment strategies and outcomes.

Main Results:

  • SINE-VNTR-Alu (SVA) retrotransposon insertion is implicated as the causative genetic mutation.
  • Clinical presentation includes progressive dystonia and parkinsonism, often accompanied by non-motor symptoms like cognitive impairment.
  • Striatal abnormalities, including atrophy, are common findings on neuroimaging.

Conclusions:

  • XDP diagnosis is primarily based on clinical evaluation and history.
  • Treatment focuses on symptomatic relief and complication prevention using medications, chemo-denervation, or surgery.
  • Further research is needed to deepen the understanding and improve management of XDP.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
665
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
347
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
102.6K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
871
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K